PMA device
Immulite/Immulite 1000 & Immulite 2000 Anti-Hbs
Siemens Healthcare Diagnostics Products, Ltd. · Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) (LOM, Class II) · First FDA decision Dec 16, 2008, newest Jan 20, 2010HIV, hepatitis and sexually transmitted infections
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
PMA pathway
Device trials
0
Naming "Immulite Immulite 1000"
MAUDE reports
32
Brand "Immulite Immulite 1000", since 2015
PubMed studies
0
Mentioning "Immulite Immulite 1000"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Immulite/Immulite 1000 & Immulite 2000 Anti-Hbs
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
- IMMULITE/IMMULITE 1000 & IMMULITE 2000 ANTI-HBSPMA supplement
P010052-S007 · Decided Jan 20, 2010 · 79 days after receipt · Normal 180 Day Track No User Fee
Device type: Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) (LOM) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
Older decisions: P010051-S005, P010050-S010, P010050-S006
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hepatitis Panel/Acute Hepatitis PanelNational determinationOn the books190.33Updated Oct 1, 2026
- Screening for Hepatitis C Virus (HCV) in AdultsNational analysisUnder reviewCAG-00436RUpdated Sep 23, 2026
- Screening for Hepatitis C Virus (HCV) in AdultsNational analysisReview closedCAG-00436NUpdated Sep 22, 2026
- Screening for Hepatitis B Virus (HBV) InfectionNational analysisReview closedCAG-00447NUpdated Sep 22, 2026
- Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.5, Other nonspecific abnormal serum enzyme levels, as a covered indication)Coding analysisReview closedCAG-00335NUpdated Sep 14, 2026
- Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.4, Elevation of Levels of Transaminase or Lactic Acid Dehydrogenase)Coding analysisReview closedCAG-00304NUpdated Sep 14, 2026
- Hepatitis Panel (Removal of ICD-9-CM Code 784.69, Other symbolic dysfunction, from the list of Codes Covered by Medicare)Coding analysisReview closedCAG-00283NUpdated Sep 14, 2026
- Screening for Hepatitis C Virus (HCV) in AdultsNational determinationOn the books210.13Updated Apr 7, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Immulite Immulite 1000", any status and sponsor, newest update first.
No registered device study names "Immulite Immulite 1000".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Immulite Immulite 1000", and for the whole product code for context.
This brand
32 reports: 32 malfunction, 0 injury, 0 death
Whole product code LOM
2,194 reports: 2,179 malfunction, 14 injury, 0 death
Newest reports for this brand
- IMMULITE/IMMULITE 1000 HCGMalfunction
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
1219913-2024-00285 · Received Apr 10, 2024 · Event dated Mar 11, 2024
Device type: System, Test, Human Chorionic Gonadotropin (DHA)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- IMMULITE 2000/IMMULITE 2000 XPi Anti HBcTerminated
Siemens Healthcare Diagnostics, Inc.
Z-1675-2018 · Started Jan 2, 2018 · Posted by FDA May 4, 2018
Reason given: Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA,...
Cause as FDA categorized it: Error in labeling · Device type: Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) (LOM)
Published research
The most relevant PubMed records for "Immulite Immulite 1000"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LOM.
- VITROS Immunodiagnostic Products Anti-HBc Reagent Pack and CalibratorOrtho-Clinical Diagnostics · PMA 2018
- Elecsys Anti-HBc IgM and PreciControl Anti-HBc IgMRoche Diagnostics Corp. · PMA 2024
- Advia Centaur Hbc IGM Readypack ReagentsSiemens Healthcare Diagnostics · PMA 2016
- Architect AusabAbbott Laboratories, Inc. · PMA 2024
- Elecsys HBsAg IIRoche Diagnostics, Inc. · PMA 2023
- Elecsys Anti-HBc IIRoche Diagnostics Corp. · PMA 2023
- Architect Core-MAbbott Laboratories · PMA 2020
- ADVIA Centaur HBsAgII (HBsII)Siemens Corp. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.